A share of Novavax Inc. (NASDAQ:NVAX) closed at $7.71 per share on Friday, down from $7.99 day before. While Novavax Inc. has underperformed by -3.50%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, NVAX fell by -76.31%, with highs and lows ranging from $33.37 to $5.61, whereas the simple moving average fell by -14.93% in the last 200 days.
Top 5 EV Tech Stocks to Buy for 2023
The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".
Click Here to Download the FREE Report.
Sponsored
On August 09, 2023, B. Riley Securities Upgraded Novavax Inc. (NASDAQ: NVAX) to Buy.
Analysis of Novavax Inc. (NVAX)
Further, the quarter-over-quarter increase in sales is 128.30%, showing a positive trend in the upcoming months.
Novavax Inc.’s future performance can be predicted by a variety of well-rounded types of analysis and research, with equity being one of the most crucial ones. The goal here is to ensure that your current return on equity of 82.30% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 0.70, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
For any stock, average volume can be an extremely valuable indicator of volatility, and NVAX is registering an average volume of 8.81M. On a monthly basis, the volatility of the stock is set at 10.31%, whereas on a weekly basis, it is put at 10.38%, with a loss of -14.05% over the past seven days. Furthermore, long-term investors anticipate a median target price of $20.60, showing growth from the present price of $7.71, which can serve as yet another indication of whether NVAX is worth investing in or should be passed over.
How Do You Analyze Novavax Inc. Shares?
Besides checking the fundamentals, you should also know how many employees own shares in the company. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 0.30%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 47.00% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
Are institutional investors increasing their holdings in NVAX shares?
The recent increase in stakes in NVAX appears to be a result of several institutional investors and hedge funds increasing their positions. SSgA Funds Management, Inc.’s position in NVAX has increased by 5.20% in the first quarter. The company now owns 11,679,428 shares of the stock, with a value of $93.44 million, following the purchase of 576,803 additional shares during the last quarter. The Vanguard Group, Inc. made another increased to its shares in NVAX during the first quarter, upping its stake by 2.56%. During the last quarter, the company picked up 258,407 additional shares for a total stake of worth $82.69 million, bringing number of shares owned by the company to 10,335,931.
During the first quarter, BlackRock Fund Advisors added a 2,104,099 position in NVAX. Shah Capital Management, Inc. purchased an additional 1.23 million shares in the last quarter, increasing its holdings by 28.93%, now holding 5.48 million shares worth $43.85 million. At the end of the first quarter, BofA Securities, Inc. increased its NVAX holdings by 34.75% and now holds 2.05 million NVAX shares valued at $16.42 million with the added 0.53 million shares during the period. NVAX shares are owned by institutional investors to the tune of 47.00% at present.
